Nam M, Han K, Lee J, Won W, Koh W, Bae J, et al. Activation of Astrocytic μ-Opioid Receptor Causes Conditioned Place Preference. Cell Rep. 2019;28:1154-1166.e5 pubmed publisher

Akoume M, Elbakry M, Veillette M, Franco A, Nada D, Labelle H, et al. A Differential Hypofunctionality of Gαi Proteins Occurs in Adolescent Idiopathic Scoliosis and Correlates with the Risk of Disease Progression. Sci Rep. 2019;9:10074 pubmed publisher

Nasrallah K, Therreau L, Robert V, Huang A, McHugh T, Piskorowski R, et al. Routing Hippocampal Information Flow through Parvalbumin Interneuron Plasticity in Area CA2. Cell Rep. 2019;27:86-98.e3 pubmed publisher

Dai W, Liu X, Bao Y, Yan B, Jiang N, Yu B, et al. Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner. Exp Mol Med. 2018;50:148 pubmed publisher

Dziedowiec E, Nayak S, Gruver K, Jennings T, Tallarida C, Rawls S. Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians. Neuroscience. 2018;386:214-222 pubmed publisher

Bao F, Li C, Chen X, Lu Y, Bao L, Zhang X. Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors. Mol Pain. 2018;14:1744806918769492 pubmed publisher

Montandon G, Wu H, Liu H, Vu M, Orser B, Horner R. δ-Subunit Containing GABAA Receptors Modulate Respiratory Networks. Sci Rep. 2017;7:18105 pubmed publisher

Schmid C, Kennedy N, Ross N, Lovell K, Yue Z, Morgenweck J, et al. Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics. Cell. 2017;171:1165-1175.e13 pubmed publisher

Ford B, Franks L, Tai S, Fantegrossi W, Stahl E, Berquist M, et al. Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development. Pharmacol Res. 2017;125:161-177 pubmed publisher

Ye Y, Bernabé D, Salvo E, Viet C, Ono K, Dolan J, et al. Alterations in opioid inhibition cause widespread nociception but do not affect anxiety-like behavior in oral cancer mice. Neuroscience. 2017;363:50-61 pubmed publisher

Lei W, Mullen N, McCarthy S, Brann C, Richard P, Cormier J, et al. Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. J Biol Chem. 2017;292:10414-10428 pubmed publisher

Mamaligas A, Cai Y, Ford C. Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission. Sci Rep. 2016;6:37834 pubmed publisher

Liu C, Lee M, Yang C, Chen C, Min M, Yang H. Morphological and physiological evidence of a synaptic connection between the lateral parabrachial nucleus and neurons in the A7 catecholamine cell group in rats. J Biomed Sci. 2015;22:79 pubmed publisher

Wang P, Ho I, Lee C. Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors. J Cell Mol Med. 2015;19:2587-96 pubmed publisher

Taylor A, Castonguay A, Taylor A, Murphy N, Ghogha A, Cook C, et al. Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci. 2015;35:8442-50 pubmed publisher

Bai X, Zhang X, Li Y, Lu L, Li B, He X. Sex differences in peripheral mu-opioid receptor mediated analgesia in rat orofacial persistent pain model. PLoS ONE. 2015;10:e0122924 pubmed publisher

Beaudry H, Mercier Blais A, Delaygue C, Lavoie C, Parent J, Neugebauer W, et al. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. Br J Pharmacol. 2015;172:2573-87 pubmed publisher

Brewer K, Baran C, Whitfield B, Jensen A, Clemens S. Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord. Front Neural Circuits. 2014;8:62 pubmed publisher

Ong E, Xue L, Olmstead M, Cahill C. Prolonged morphine treatment alters ? opioid receptor post-internalization trafficking. Br J Pharmacol. 2015;172:615-29 pubmed publisher

Chen W, McRoberts J, Marvizón J. ?-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain. Neuroscience. 2014;267:67-82 pubmed publisher

Zhou L, Lovell K, Frankowski K, Slauson S, Phillips A, Streicher J, et al. Development of functionally selective, small molecule agonists at kappa opioid receptors. J Biol Chem. 2013;288:36703-16 pubmed publisher

Vicente Sánchez A, Sánchez Blázquez P, Rodríguez Muñoz M, Garzón J. HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity. Mol Brain. 2013;6:42 pubmed publisher

Kharmate G, Rajput P, Lin Y, Kumar U. Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells. Cancer Cell Int. 2013;13:93 pubmed publisher

Rajasekaran M, Brents L, Franks L, Moran J, Prather P. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol Appl Pharmacol. 2013;269:100-8 pubmed publisher

Morse M, Sun H, Tran E, Levenson R, Fang Y. Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family. BMC Pharmacol Toxicol. 2013;14:17 pubmed publisher

Sarkar D, Sengupta A, Zhang C, Boyadjieva N, Murugan S. Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth. J Biol Chem. 2012;287:16734-47 pubmed publisher

Krook Magnuson E, Luu L, Lee S, Varga C, Soltesz I. Ivy and neurogliaform interneurons are a major target of ?-opioid receptor modulation. J Neurosci. 2011;31:14861-70 pubmed publisher

Gruol D, Nelson T, Hao C, Michael S, Vukojevic V, Ming Y, et al. Ethanol alters opioid regulation of Ca(2+) influx through L-type Ca(2+) channels in PC12 cells. Alcohol Clin Exp Res. 2012;36:443-56 pubmed publisher

Morse M, Tran E, Sun H, Levenson R, Fang Y. Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target. PLoS ONE. 2011;6:e25643 pubmed publisher

Reyes B, Vakharia K, Ferraro T, Levenson R, Berrettini W, van Bockstaele E. Opiate agonist-induced re-distribution of Wntless, a mu-opioid receptor interacting protein, in rat striatal neurons. Exp Neurol. 2012;233:205-13 pubmed publisher

Beaudry H, Dubois D, Gendron L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci. 2011;31:13068-77 pubmed publisher

Lee C, Yan J, Chiang Y, Hung T, Wang H, Chiou L, et al. Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human ?-opioid and opioid receptor-like 1 receptors. Neurochem Res. 2011;36:2008-21 pubmed publisher

Nassirpour R, Bahima L, Lalive A, Lüscher C, Lujan R, Slesinger P. Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J Neurosci. 2010;30:13419-30 pubmed publisher

Wang H, Zhao B, Zhong Y, Li K, Li Z, Wang Q, et al. Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci U S A. 2010;107:13117-22 pubmed publisher

Lorier A, Funk G, Greer J. Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy. PLoS ONE. 2010;5:e8766 pubmed publisher

Hull L, Llorente J, Gabra B, Smith F, Kelly E, Bailey C, et al. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. J Pharmacol Exp Ther. 2010;332:1127-35 pubmed publisher

Maione S, Starowicz K, Cristino L, Guida F, Palazzo E, Luongo L, et al. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia. J Neurophysiol. 2009;101:2411-22 pubmed publisher

Garzón J, de la Torre Madrid E, Rodríguez Muñoz M, Vicente Sánchez A, Sánchez Blázquez P. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Mol Pain. 2009;5:11 pubmed publisher

Kokkola T, Savinainen J, Mönkkönen K, Retamal M, Laitinen J. S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner. BMC Cell Biol. 2005;6:21 pubmed